Indefinite Delivery Contract 36E79723D0001
Award Date
1/15/23
Last Date to Order
1/14/26
Federal Agency
National Acquisition Center
Awardee
Sandoz Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award is for the supply of Amoxicillin/Clavulanate Potassium (K) Suspension products to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Services (IHS). The contract was awarded to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, and a division of Novartis. The contract has a base year from January 15, 2023, to January 14, 2024, with four one-year option periods, for a total potential...
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...
The federal government has awarded an Indefinite Delivery Contract to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars, to supply a variety of prescription medications through the VA and DoD pharmaceutical prime vendor programs. The contract, valued up to $164,608.40, has a base year plus four one-year option periods, and aims to meet the medication needs of veterans, active duty military personnel, federal inmates, and Native American populations served by the...
This Federal Supply Schedule contract is a multiple award indefinite delivery vehicle (IDV) awarded by the Department of Veterans Affairs National Acquisition Center to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The contract, with a ceiling value of $683,208,960.00, covers a wide range of prescription medications such as antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications, and injectables. These products are intended to meet the medication...
The Department of Veterans Affairs (VA) National Acquisition Center awarded a single-award Indefinite Delivery Contract (IDC) to Sandoz Inc., a global leader in generic pharmaceuticals and biosimilars. The IDC, valued at a ceiling of $236,745.90, is for the supply of TRIFLUOPERAZINE tablets to the VA, Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS) healthcare networks. The contract has a base period of one year, with four one-year option periods, and...
The federal contract IDV award is a single award Indefinite Delivery Contract between the Department of Veterans Affairs (VA) National Acquisition Center and Sandoz Inc., a global pharmaceutical company, to provide a variety of prescription medications through the VA and Department of Defense (DoD) pharmaceutical prime vendor programs. The contract has a base period of performance from May 30, 2021 to May 29, 2022 with four one-year option periods, and a ceiling value of $9,803,319.55. The...
The Department of Veterans Affairs National Acquisition Center awarded an indefinite delivery contract to Sandoz Inc. for the delivery of amitriptyline hydrochloride tablets. The single award contract has a potential value of $14.1 million over a one year base period and four one year option periods extending to March 6, 2023. The originating pre-solicitation notice sought offers for an unrestricted procurement to supply amitriptyline hydrochloride tablets to meet the estimated annual...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business that is certified as an economically disadvantaged woman-owned small business. The contract has a total ceiling value of $3,129,016.00 and a period of performance from November 16, 2020 to November 15, 2025. It is a single-award IDC that allows for the ordering of various pharmaceutical products...
The Department of Veterans Affairs National Acquisition Center has awarded Organon LLC a single-award Indefinite Delivery Contract (IDC) worth up to $119,538,562.32 to provide Infliximab Injection 100 mg/vial, a biosimilar medication, to the VA, Bureau of Prisons, and Indian Health Service. The contract has a 1-year base period starting September 1, 2023 with four 1-year option periods, for a total potential period of performance through August 31, 2026. This IDC supports the VA's Pharmaceutical...
The federal contract IDV award is for the supply of Cefpodoxime Proxetil Tablets to the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract was awarded to Golden State Medical Supply, Inc., a for-profit pharmaceutical manufacturer and distributor based in Camarillo, California. The contract has a base period of one year from July 22, 2023 to July 21, 2024, with four one-year option periods, for a total potential...